Business
Currency:USD
2023/FY
Stock NameRevenueRatio
VIMIZIM701.05M28.98%
VOXZOGO469.88M19.42%
NAGLAZYME420.29M17.37%
PALYNZIQ303.92M12.56%
KUVAN180.77M7.47%
BRINEURA161.89M6.69%
ALDURAZYME131.25M5.43%
Royalty and other revenues46.69M1.93%
ROCTAVIAN3.49M0.14%
View all
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States771.31M31.88%
Europe669.33M27.67%
Rest of World468.21M19.35%
Latin America332.44M13.74%
ALDURAZYME net product revenues marketed by Sanofi131.25M5.43%
Royalty and other revenues46.69M1.93%
View all
